[e-farmacos] Drug Safety Update n 3, 2007

["Madurga, Mariano" <mmadurga@agemed.es>]

Estimadas y estimados,

Acaba de distribuir la MHRA el nuevo boletín Drug Safety Update, n 3, 2007:

Piroxicam: new restrictions, including specialist initiation 2
Ketoprofen and ketorolac: gastrointestinal risk 3
Inhaled corticosteroids: pneumonia 5
Pneumovax II: tolerability of re-vaccination 6
Bisphosphonates: osteonecrosis of the jaw 7
Lorazepam: reduction of recommended maximum daily dose 8
Please continue to report 9
Botulinum toxin products: rare but serious risk
Rosiglitazone and pioglitazone: cardiovascular safety and fracture risk 10
Recent letters to healthcare professionals 11
Lumiracoxib and hepatotoxicity: prescribing update 11
Latest safety information 11
Field safety notices for medical devices 11
Consultation-MHRA strategy 11

Se puede encontrar el boletin en: http://www.mhra.gov.uk/home/idcplg?IdcService=SS_GET_PAGE&useSecondary=true&ssDocName=CON2032518&ssTargetNodeId=1100 

Un abrazo,

Mariano Madurga Sanz
Jefe de Servicio de Coordinación del SEFV
Division de Farmacoepidemiologia y Farmacovigilancia
Agencia Espanhola de Medicamentos y Productos Sanitarios
Correo-e: mmadurga@agemed.es <mailto:mmadurga@agemed.es>  
Internet: www.agemed.es <http://correoweb.msc.es/exchweb/bin/redir.asp?URL=http://www.agemed.es>